Skip to Main Content

Paper Details

The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.
J Natl Cancer Inst
17
2021
Cancer, RNA, Tumor, cancer, germline, methylation arrays, normal tissue, nucleic, patients, tumors
Author NameAffiliation
Louis M StaudtCenter for Cancer Genomics, National Cancer Institute
Louis M StaudtCenter for Cancer Genomics, National Cancer Institute
David A WheelerBaylor College of Medicine
David A WheelerBaylor College of Medicine
Linghua WangThe University of Texas MD Anderson Cancer Center
Viktoriya KorchinaBaylor College of Medicine
Jean Claude ZenklusenCenter for Cancer Genomics, National Cancer Institute
Jean Claude ZenklusenCenter for Cancer Genomics, National Cancer Institute
Carol J WeilNational Cancer Institute
Roy W TarnuzzerCenter for Cancer Genomics, National Cancer Institute
Julie M Gastier-FosterNationwide Children's Hospital, USA Van Andel Research Institute
Julie M Gastier-FosterNationwide Children's Hospital, USA Van Andel Research Institute
Jay BowenNationwide Children's Hospital, USA Van Andel Research Institute
Jay BowenNationwide Children's Hospital, USA Van Andel Research Institute
Kristen LeraasNationwide Children's Hospital, USA Van Andel Research Institute
Kristen LeraasNationwide Children's Hospital, USA Van Andel Research Institute
Hui ShenVan Andel Research Institute
Hui ShenVan Andel Research Institute
Peter W LairdVan Andel Research Institute
Peter W LairdVan Andel Research Institute
Vincent A MillerFoundation Medicine Inc
Thomas J GiordanoUniversity of Michigan ann arbor
  • 1 - 22

Datasets